Market closed · Next open: Monday 9:30 AM ET
Last update: Sep 25, 2026, 6:07 PM ET
Tenet Healthcare Corporation
$259.71▲ 4.08% today
Market Closed

Why Tenet Healthcare Corporation (THC) stock moved

Updated Sep 26, 2026

Tenet Healthcare Corporation (THC) shares rose 4.1% to $259.71 as of September 26, 2026, a moderate gain from the prior close of $249.54. BestStocks flagged the session as a major change for THC. The move is tied to price move up. Below, we break down what changed for THC, why it matters for investors, how the stock reacted, and the catalysts on the calendar.

What happened

THC climbed 4.1% to $259.71

THC rose 4.1% in its latest session, moving from $249.54 to $259.71.

Material / EarningsLow confidence
Rel. volume
0.6×
Below Avg
Vs peers
—
No comparable peers
Market cap
$20.9B
New York Stock Exchange
Analyst target
$283
+9.1% vs price
Price chart
Aug 26 – Sep 25
EEE$249$262$275Aug 26Sep 2Sep 11Sep 18Sep 25
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details

What it means for Tenet Healthcare Corporation investors

For Tenet Healthcare Corporation investors, the balance of recent signals points to a bullish shift. On the constructive side: Material positive event; Positive 4.1% session move. Weighing against that: Tenet Healthcare Corporation (THC) moved -5.71% from $194.81 to $183.69 on 2026-07-14; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $283.36, implying +9.1% upside from $259.71. BestStocks rates the overall signal quality low (51/100). With earnings roughly 31 days out, the next report is the most likely near-term test of the move.

THC price reaction

THC last traded at $259.71, up $10.17 (+4.08%) from the previous close of $249.54. The session traded on 0.6× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $249.54 and $274.19, and it currently sits about 41% of the way up that band.

Bullish and bearish analyst opinions on Tenet Healthcare Corporation (THC)

The consensus analyst price target on Tenet Healthcare Corporation (THC) is $283.36, 9.1% above the recent $259.71. Over the past 90 days analysts logged 0 upgrades, 13 maintains, and 0 downgrades. Here is how the bullish and bearish cases on THC line up.

The bullish case

  • Wall Street's consensus price target of $283.36 implies +9.1% upside from $259.71.
  • The Street's most bullish target is $308.00 (+18.6%).
  • Material positive event.
  • Positive 4.1% session move.
  • Positive price momentum.

The bearish case

  • The most bearish analyst target is $242.00 (-6.8%).
  • Tenet Healthcare Corporation (THC) moved -5.71% from $194.81 to $183.69 on 2026-07-14.
Bull vs bear balanceBullish Shift
BearishNeutralBullish

Weighing both sides, BestStocks' composite read of recent signals is bullish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.

Analyst price targets and ratings are FMP consensus figures as of Sep 25, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.

Analyst expectations
Consensus target: $283+9.1%
= 13 maintains
Leerink Partners maintained Outperform · 2026-09-18
SEC filings watch
10-Q2026-07-29
Quarterly financial results
medium
8-K2026-07-23
Material event — review for impact
high
8-K2026-05-29
Material event — review for impact
high
Peer context
THC+4.1%

Previous notable changes for THC

Material / Earnings2026-09-09+3.9%
Tenet Healthcare Corporation (THC) moved +4.56% from $257.35 to $269.08 on 2026-09-09. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was near its 5-day average, suggesting the move was not driven by unusual trading activity.
Material / Earnings2026-09-02-2.7%
Tenet Healthcare Corporation (THC) moved -3.23% from $267.16 to $258.53 on 2026-09-02. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was 1.3x the 5-day average, modestly elevated.
Valuation2026-08-12+2.8%via Yahoo Finance ↗
Tenet Healthcare (THC) rose 2.58% to $266.15, holding near recent highs following its July 24 Q2 earnings beat (adjusted EPS $6.12 vs. $4.26 consensus) and raised full-year 2026 guidance, per web sources. Volume of 228,800 shares is running 0.21x of historical average, indicating below-average participation for this point in the session.
Material / Earnings2026-08-06-1.9%
THC moved -2.84% from its $264.15 open to a $256.64 close on 2026-08-06.
Upcoming catalysts & outlook
Next earnings
2026-10-27 (est.)
in 31 days
10-Q Filing (est.)
2026-10-28
Medium impact
Thesis shift
Bullish Shift
bullish signal
Risk level
Medium
from change events

Frequently asked questions about THC

Why did Tenet Healthcare Corporation (THC) stock move?

THC rose 4.1% to $259.71. No single company-specific catalyst was confirmed during the move window, and it looks technical.

How much did THC stock rise?

THC gained 4.08% ($10.17) versus the prior close of $249.54, last trading at $259.71 on 0.6× average volume.

When is Tenet Healthcare Corporation's next earnings date?

THC's next earnings report is estimated for 2026-10-27 — about 31 days away.

What is the analyst price target for THC?

The consensus analyst price target for THC is $283.36, about 9.1% above the current $259.71. Over the past 90 days, analysts recorded 0 upgrades, 13 maintains, and 0 downgrades.

How BestStocks tracks THC

This page is generated automatically by BestStocks' change-detection system after price move up was detected and verified against independent data sources. It draws on 20 tracked change events for THC, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of September 26, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.

Data sources
FMP real-time & historical price dataSEC EDGAR filingsFMP earnings & estimatesAnalyst ratings & price targets (FMP)Earnings calendar (FMP)
Educational research tool — not personalized investment advice. Data may be delayed.